These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 1514213

  • 1. [Polychemotherapy in advanced bladder cancer. Practicality and clinical results].
    Klän R, Knispel H, Huland H.
    Urologe A; 1992 Jul; 31(4):247-50. PubMed ID: 1514213
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant polychemotherapy of nonorgan-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience.
    Stöckle M, Meyenburg W, Wellek S, Voges GE, Rossmann M, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.
    J Urol; 1995 Jan; 153(1):47-52. PubMed ID: 7966789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
    Rassweiler J, Rüther U, Bäuerle K, Bub P, Jipp P, Eisenberger F.
    Urologe A; 1989 Jan; 28(1):25-30. PubMed ID: 2922897
    [Abstract] [Full Text] [Related]

  • 6. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
    Hata M, Miyanaga N, Tokuuye K, Saida Y, Ohara K, Sugahara S, Kagei K, Igaki H, Hashimoto T, Hattori K, Shimazui T, Akaza H, Akine Y.
    Int J Radiat Oncol Biol Phys; 2006 Apr 01; 64(5):1371-9. PubMed ID: 16580495
    [Abstract] [Full Text] [Related]

  • 7. Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
    Keating JP, Zincke H, Hahn RG, Morgan WR.
    Prog Clin Biol Res; 1990 Apr 01; 353():119-27. PubMed ID: 2217409
    [No Abstract] [Full Text] [Related]

  • 8. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
    Sella A, Flex D, Gafni D, Rabinovitz O, Sulkes A, Baniel J.
    Harefuah; 1999 Feb 15; 136(4):268-71, 340, 339. PubMed ID: 10914214
    [Abstract] [Full Text] [Related]

  • 9. [Neoadjuvant chemotherapy (M-VAC) in invasive cancer of the bladder. Our experience].
    González Enguita C, Caro Cebrián C, Roncalés Badal A, Gil Sanz MJ, Martínez Bengoechea J, Rioja Sanz LA.
    Arch Esp Urol; 1990 Feb 15; 43 Suppl 2():197-204. PubMed ID: 2096779
    [Abstract] [Full Text] [Related]

  • 10. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
    Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D.
    Eur Cytokine Netw; 1996 Sep 15; 7(3):395-9. PubMed ID: 8954183
    [Abstract] [Full Text] [Related]

  • 11. Quality of life in patients with advanced bladder cancer treated by tumorectomy and systemic adjuvant polychemotherapy (M-VAC). Our experience in 14 cases.
    Valente R, Marini F, Signori GB, Martino F.
    Arch Esp Urol; 1989 Sep 15; 42(1):87-9. PubMed ID: 2712609
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD, Ozen H, Uluçay S, Sahin A, Ergen A, Koçal C, Remzi D.
    Int Urol Nephrol; 1993 Sep 15; 25(4):351-7. PubMed ID: 8276565
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Is down-staging of advanced bladder cancer by neoadjuvant chemotherapy possible?--MVEC protocol].
    Hoch V, Noll F, Schreiter F.
    Urologe A; 1992 Jul 15; 31(4):243-6. PubMed ID: 1514212
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep 15; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 16. Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study.
    Vikram B, Chadha M, Malamud SC, Hecht H, Grabstald H.
    Cancer; 1998 Mar 01; 82(5):918-22. PubMed ID: 9486582
    [Abstract] [Full Text] [Related]

  • 17. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb 01; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 18. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov 01; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F, Reese J, Torti FM.
    J Urol; 1996 Feb 01; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [Abstract] [Full Text] [Related]

  • 20. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 01; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.